Lv1
20 积分 2024-06-12 加入
1. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
2小时前
已完结
Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments
5个月前
已完结
Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of nonsmall cell lung cancer
5个月前
已完结
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients
5个月前
已完结
皖公网安备34019202002308
